enroll
-
Hospitals
InVivo Therapeutics receives conditional FDA approval for INSPIRE pivotal probable benefit study
InVivo Therapeutics announced the FDA has given the company conditional approval to convert an ongoing study into the pivotal probable…
Read More » -
Recon
OrthoSpace Enrolls First Patients in US IDE Study
CAESAREA, Israel, July 6, 2015 /PRNewswire/ — OrthoSpace Ltd. (“OrthoSpace” or “Company”) announced today the enrollment of the first three patients in its…
Read More » -
Recon
Implanet enrolls first patient in a major multi-center clinical study led by the Ohio State University
Bordeaux, Boston, June 16, 2015 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today…
Read More »